Phase II prospective single-institutional study.
The aim of this Phase II prospective single-institutional study is to assess feasibility and early complications rate of Telelap ALF-X surgical treatment in obese patients affected by gynecological disease.
Inclusion Criteria:
Exclusion Criteria:
gueliallettis@gmail.com
Rome, Rome 00168, Italy
giovanni.scambia@rm.unicatt.it+39-06-30156279